NDC 0006-0335-13
BELSOMRA 20 mg/1
suvorexant · TABLET, FILM COATED
Belsomra (suvorexant) is a prescription tablet taken by mouth to treat insomnia by blocking orexin receptors in the brain, which helps promote sleep. It comes in a 20 mg strength and belongs to a class of medications called orexin receptor antagonists.
Key Facts
- Brand Name
- BELSOMRA
- Generic Name
- suvorexant
- NDC Code (Package)
0006-0335-13- NDC Code (Product)
0006-0335- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 20 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule IV (Controlled)
- Application #
- NDA204569
- Drug Class
- Orexin Receptor Antagonist [EPC]
- Marketing Start
- 08/29/2014
Recall History
No Recall HistoryView Full Drug Page
BELSOMRA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.